However, they contrast with Gorson et al. [10] who found that CIDP-MGUS patients did not have a more indolent course despite the fact that weakness was less common in this group, and Bromberg et al. who found that CIDP-MGUS cannot be distinguished from CIDP-I on the basis of NCS [11]. The gene discussed is PMP22; the disease is chronic inflammatory demyelinating polyradiculoneuropathy.